Monogenic Kidney Stone - Genetic Testing
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT03305835
- Status
- Recruiting
Conditions
- Rare Kidney Stone Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
This study will attempt to identify the specific gene (coded in the DNA) and changes (mutations) within that gene that are the cause of monogenic kidney stone disease. This study will help researchers determine the characteristics of the stone disease associated with specific genes and mutations. This information may help develop more effective treatments for monogenic kidney stone diseases.
Key Dates
- Start date
- Sep 11, 2017
- Status verified
- Apr 2026
- Primary completion
- Feb 29, 2028
- Completion
- Feb 29, 2028
Study Design
- Enrollment
- 6,000 participants (estimated)
Primary Outcome Measure
symptomatic onset of monogenic stone disease [ Time Frame: 5 years ]
Central Contacts
- RKSC Study Coordinators800-270-4637
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 |
Find similar trials in Rochester, MN
By research site